CASSELLA JAMES V (Chief Development Officer) sold 2.1% of their position (3.76K shares) of CONCERT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $31.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/16/2023ACC: 0001209191-23-009949
Officer· Chief Development Officer
Since Jan 2019
-3.76K
Net shares
Net seller
$31.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.76K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.76K
Price / share
$8.34
Trade value
$31.38K
% of position
2.1%
2/15/2023
176.82K→173.06K
Total
Net shares
−3.76K
Net value
-$31.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2023 | S · Sale | −3.76K | $8.34 | $31.38K | 2.1% | 176.82K | 173.06K |
| Total | −3.76K | -$31.38K | ||||||
Derivative Transactions0
No derivative transactions reported